Cargando…

Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer

Non–small‐cell lung cancer (NSCLC) has become the most lethal human cancer because of the high rate of metastasis. Hence, clarifying the molecular mechanism underlying NSCLC metastasis is very important to improve the prognosis of patients with NSCLC. Long non‐coding RNAs (LncRNAs) are a class of RN...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Cheng, Wang, Lixin, Gong, Chenyuan, Wu, Wenbin, Yao, Chao, Zhu, Shiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131947/
https://www.ncbi.nlm.nih.gov/pubmed/32048814
http://dx.doi.org/10.1111/jcmm.15054
_version_ 1783517349940297728
author Fang, Cheng
Wang, Lixin
Gong, Chenyuan
Wu, Wenbin
Yao, Chao
Zhu, Shiguo
author_facet Fang, Cheng
Wang, Lixin
Gong, Chenyuan
Wu, Wenbin
Yao, Chao
Zhu, Shiguo
author_sort Fang, Cheng
collection PubMed
description Non–small‐cell lung cancer (NSCLC) has become the most lethal human cancer because of the high rate of metastasis. Hence, clarifying the molecular mechanism underlying NSCLC metastasis is very important to improve the prognosis of patients with NSCLC. Long non‐coding RNAs (LncRNAs) are a class of RNA molecules longer than 200 nucleotides, which can participate in diverse biological processes. About 18% of human LncRNAs were recently found to be associated with tumours. Many studies indicated that aberrant expression of LncRNAs played key roles in the progression and metastasis of NSCLC. According to the function in tumours, LncRNAs can be divided into two classes: oncogenic LncRNAs and tumour‐suppressor LncRNAs. In this review, we summarized the main molecular mechanism of LncRNAs regulating NSCLC metastasis, including three aspects: (a) LncRNAs interact with miRNAs as ceRNAs; (b) LncRNAs bind with target proteins; and (c) LncRNAs participate in the transduction of different signal pathways. Then, LncRNAs can exert their function to regulate the metastasis of NSCLC through influencing the progression of epithelial‐mesenchymal transition (EMT) and the properties of cancer stem cell (CSC). But, it is necessary to do some further research to demonstrate the LncRNAs particular regulatory mechanism of inhibiting the metastasis of NSCLC and explore new drugs targeting LncRNAs.
format Online
Article
Text
id pubmed-7131947
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71319472020-04-06 Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer Fang, Cheng Wang, Lixin Gong, Chenyuan Wu, Wenbin Yao, Chao Zhu, Shiguo J Cell Mol Med Reviews Non–small‐cell lung cancer (NSCLC) has become the most lethal human cancer because of the high rate of metastasis. Hence, clarifying the molecular mechanism underlying NSCLC metastasis is very important to improve the prognosis of patients with NSCLC. Long non‐coding RNAs (LncRNAs) are a class of RNA molecules longer than 200 nucleotides, which can participate in diverse biological processes. About 18% of human LncRNAs were recently found to be associated with tumours. Many studies indicated that aberrant expression of LncRNAs played key roles in the progression and metastasis of NSCLC. According to the function in tumours, LncRNAs can be divided into two classes: oncogenic LncRNAs and tumour‐suppressor LncRNAs. In this review, we summarized the main molecular mechanism of LncRNAs regulating NSCLC metastasis, including three aspects: (a) LncRNAs interact with miRNAs as ceRNAs; (b) LncRNAs bind with target proteins; and (c) LncRNAs participate in the transduction of different signal pathways. Then, LncRNAs can exert their function to regulate the metastasis of NSCLC through influencing the progression of epithelial‐mesenchymal transition (EMT) and the properties of cancer stem cell (CSC). But, it is necessary to do some further research to demonstrate the LncRNAs particular regulatory mechanism of inhibiting the metastasis of NSCLC and explore new drugs targeting LncRNAs. John Wiley and Sons Inc. 2020-02-12 2020-03 /pmc/articles/PMC7131947/ /pubmed/32048814 http://dx.doi.org/10.1111/jcmm.15054 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Fang, Cheng
Wang, Lixin
Gong, Chenyuan
Wu, Wenbin
Yao, Chao
Zhu, Shiguo
Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer
title Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer
title_full Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer
title_fullStr Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer
title_full_unstemmed Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer
title_short Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer
title_sort long non‐coding rnas: how to regulate the metastasis of non–small‐cell lung cancer
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131947/
https://www.ncbi.nlm.nih.gov/pubmed/32048814
http://dx.doi.org/10.1111/jcmm.15054
work_keys_str_mv AT fangcheng longnoncodingrnashowtoregulatethemetastasisofnonsmallcelllungcancer
AT wanglixin longnoncodingrnashowtoregulatethemetastasisofnonsmallcelllungcancer
AT gongchenyuan longnoncodingrnashowtoregulatethemetastasisofnonsmallcelllungcancer
AT wuwenbin longnoncodingrnashowtoregulatethemetastasisofnonsmallcelllungcancer
AT yaochao longnoncodingrnashowtoregulatethemetastasisofnonsmallcelllungcancer
AT zhushiguo longnoncodingrnashowtoregulatethemetastasisofnonsmallcelllungcancer